| scholarly article | Q13442814 |
| P2093 | author name string | Richard D Semba | |
| P2860 | cites work | A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease | Q24531755 |
| Characterization of plasma unsaturated lysophosphatidylcholines in human and rat | Q24531892 | ||
| Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial | Q24607545 | ||
| Elucidation of phosphatidylcholine composition in krill oil extracted from Euphausia superba | Q24634419 | ||
| Shotgun lipidomics reveals the temporally dependent, highly diversified cardiolipin profile in the mammalian brain: temporally coordinated postnatal diversification of cardiolipin molecular species with neuronal remodeling | Q24645695 | ||
| Mfsd2a encodes a novel major facilitator superfamily domain-containing protein highly induced in brown adipose tissue during fasting and adaptive thermogenesis | Q24653866 | ||
| Metabolomics and Type 2 Diabetes: Translating Basic Research into Clinical Application | Q26774386 | ||
| Structural basis of transport of lysophospholipids by human serum albumin | Q27656406 | ||
| Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid | Q28115048 | ||
| Autotaxin: structure-function and signaling | Q28307790 | ||
| Evidence for a membrane defect in Alzheimer disease brain | Q28343061 | ||
| Biosynthesis, remodeling and turnover of mitochondrial cardiolipin | Q28395064 | ||
| Major facilitator superfamily domain-containing protein 2a (MFSD2A) has roles in body growth, motor function, and lipid metabolism | Q28485382 | ||
| Large-scale metabolomic profiling identifies novel biomarkers for incident coronary heart disease | Q28542665 | ||
| Deletion of Abca7 increases cerebral amyloid-β accumulation in the J20 mouse model of Alzheimer's disease | Q28588308 | ||
| Novel bioactive glycerol-based lysophospholipids: new data -- new insight into their function | Q30574382 | ||
| Potential for primary prevention of Alzheimer's disease: an analysis of population-based data | Q30836810 | ||
| Deregulation of sphingolipid metabolism in Alzheimer's disease | Q33693061 | ||
| Neuroprotectin D1 upregulates Iduna expression and provides protection in cellular uncompensated oxidative stress and in experimental ischemic stroke | Q33721387 | ||
| Transport of fatty acids across membranes by the diffusion mechanism. | Q33724950 | ||
| Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry | Q33947437 | ||
| Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis | Q34007818 | ||
| DHA status of vegetarians | Q34017902 | ||
| Lecithin cholesterol acyltransferase | Q34101276 | ||
| The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. | Q34117959 | ||
| Identification of metabolic biomarkers to diagnose epithelial ovarian cancer using a UPLC/QTOF/MS platform | Q34142972 | ||
| Separation and quantification of 2-acyl-1-lysophospholipids and 1-acyl-2-lysophospholipids in biological samples by LC-MS/MS | Q34238735 | ||
| Lysophosphatidylcholine as a preferred carrier form of docosahexaenoic acid to the brain. | Q34322455 | ||
| Plasma lysophosphatidylcholine levels are reduced in obesity and type 2 diabetes. | Q34358476 | ||
| Bioavailability and potential uses of vegetarian sources of omega-3 fatty acids: a review of the literature | Q34386753 | ||
| Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease | Q34468561 | ||
| Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer's disease patients and its relationship to acetyl CoA content | Q34470129 | ||
| Inactivating mutations in MFSD2A, required for omega-3 fatty acid transport in brain, cause a lethal microcephaly syndrome | Q34477725 | ||
| The overlap between vascular disease and Alzheimer's disease--lessons from pathology | Q34484708 | ||
| Identification and characterization of a major liver lysophosphatidylcholine acyltransferase | Q34735966 | ||
| Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex | Q35218379 | ||
| Omega-3 fatty acids and risk of cognitive decline in the elderly: a meta-analysis of randomized controlled trials | Q35646725 | ||
| Comparative lipidomic analysis of mouse and human brain with Alzheimer disease. | Q35710041 | ||
| Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity | Q35828524 | ||
| Linking lipids to Alzheimer's disease: cholesterol and beyond | Q35875480 | ||
| Modification of egg yolk fatty acids profile by using different oil sources. | Q35909349 | ||
| Plasma lyso-phosphatidylcholine concentration is decreased in cancer patients with weight loss and activated inflammatory status | Q35924910 | ||
| Targeted metabolomics for discrimination of systemic inflammatory disorders in critically ill patients | Q36020293 | ||
| Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer's disease | Q36132033 | ||
| The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age. | Q36302559 | ||
| Novel biomarkers for pre-diabetes identified by metabolomics | Q36321634 | ||
| Role of ABCA7 loss-of-function variant in Alzheimer's disease: a replication study in European-Americans | Q36361585 | ||
| Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study | Q36513866 | ||
| Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach | Q36560652 | ||
| Phospholipids and Alzheimer's disease: alterations, mechanisms and potential biomarkers | Q36590043 | ||
| Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease | Q36604677 | ||
| ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology | Q36741016 | ||
| Structural Insights into the Transport Mechanism of the Human Sodium-dependent Lysophosphatidylcholine Transporter MFSD2A. | Q36849973 | ||
| New insights into the roles of proteins and lipids in membrane transport of fatty acids. | Q37010813 | ||
| Phenotypic characteristics of Alzheimer patients carrying an ABCA7 mutation | Q37029248 | ||
| Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals | Q37100094 | ||
| Intestinal lipid absorption | Q37216738 | ||
| Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer's Coordinating Centre | Q37380546 | ||
| Metabolism and atherogenic disease association of lysophosphatidylcholine | Q37537825 | ||
| A Non-Targeted Liquid Chromatographic-Mass Spectrometric Metabolomics Approach for Association with Coronary Artery Disease: An Identification of Biomarkers for Depiction of Underlying Biological Mechanisms | Q37635546 | ||
| Fatty acid transport into the brain: of fatty acid fables and lipid tails | Q37911679 | ||
| Omega-3 fatty acids and brain resistance to ageing and stress: body of evidence and possible mechanisms | Q38080357 | ||
| Effect of n-3 PUFA supplementation on cognitive function throughout the life span from infancy to old age: a systematic review and meta-analysis of randomized controlled trials | Q38269824 | ||
| Lysophosphatidic acid as a lipid mediator with multiple biological actions | Q38286968 | ||
| Phospholipid Remodeling in Physiology and Disease | Q58086440 | ||
| The lysolipid transporter Mfsd2a regulates lipogenesis in the developing brain | Q58801216 | ||
| Alzheimer's disease | Q60313667 | ||
| Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 | Q60641769 | ||
| Quantification of Lysophosphatidylcholine Species by High-Throughput Electrospray Ionization Tandem Mass Spectrometry (ESI-MS/MS) | Q61863030 | ||
| Patterns in metabolite profile are associated with risk of more aggressive prostate cancer: A prospective study of 3,057 matched case–control sets from EPIC | Q63865883 | ||
| An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases | Q64057248 | ||
| Low plasma lysophosphatidylcholines are associated with impaired mitochondrial oxidative capacity in adults in the Baltimore Longitudinal Study of Aging | Q64261839 | ||
| Composition of phospholipids of white muscle of six tuna species | Q71040876 | ||
| Preferential incorporation of sn-2 lysoPC DHA over unesterified DHA in the young rat brain | Q72850709 | ||
| Effects of long-term feeding of marine oils with different positional distribution of eicosapentaenoic and docosahexaenoic acids on lipid metabolism, eicosanoid production, and platelet aggregation in hypercholesterolemic rats | Q77430763 | ||
| Cognitive function after supplementation with B vitamins and long-chain omega-3 fatty acids: ancillary findings from the SU.FOL.OM3 randomized trial | Q84143085 | ||
| Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators | Q88660941 | ||
| Targeted Metabolomics Shows Low Plasma Lysophosphatidylcholine 18:2 Predicts Greater Decline of Gait Speed in Older Adults: The Baltimore Longitudinal Study of Aging | Q88774089 | ||
| Group 1B phospholipase A2 in metabolic and inflammatory disease modulation | Q90024444 | ||
| Aging and cerebrovascular lesions in pure and in mixed neurodegenerative and vascular dementia brains: a neuropathological study | Q90220038 | ||
| Dietary lysophosphatidylcholine-EPA enriches both EPA and DHA in the brain: potential treatment for depression | Q90365406 | ||
| Homozygous mutation in MFSD2A, encoding a lysolipid transporter for docosahexanoic acid, is associated with microcephaly and hypomyelination | Q90458054 | ||
| Enrichment of brain docosahexaenoic acid (DHA) is highly dependent upon the molecular carrier of dietary DHA: lysophosphatidylcholine is more efficient than either phosphatidylcholine or triacylglycerol | Q91007756 | ||
| Vascular dysfunction-The disregarded partner of Alzheimer's disease | Q91042624 | ||
| The Role of Lipids and Membranes in the Pathogenesis of Alzheimer's Disease: A Comprehensive View | Q91399062 | ||
| Intra- and inter-individual metabolic profiling highlights carnitine and lysophosphatidylcholine pathways as key molecular defects in type 2 diabetes | Q91622597 | ||
| How the plasma lysophospholipid and unesterified fatty acid pools supply the brain with docosahexaenoic acid | Q91654985 | ||
| Characterization of the unique In Vitro effects of unsaturated fatty acids on the formation of amyloid β fibrils | Q91768531 | ||
| Tetra-linoleoyl cardiolipin depletion plays a major role in the pathogenesis of sarcopenia | Q92018904 | ||
| Effect of Dietary Oil Rich in Docosahexaenoic Acid-Bound Lysophosphatidylcholine Prepared from Fishery By-Products on Lipid and Fatty Acid Composition in Rat Liver and Brain | Q92321420 | ||
| The role of ABCA7 in Alzheimer's disease: evidence from genomics, transcriptomics and methylomics | Q92566493 | ||
| Understanding the Role of Systemic Inflammation in Alzheimer's Disease | Q93039213 | ||
| Plasma 1-palmitoyl-2-linoleoyl phosphatidylcholine. Evidence for extensive phospholipase A1 hydrolysis and hepatic metabolism of the products | Q44944769 | ||
| Impact of feed supplementation with different omega-3 rich microalgae species on enrichment of eggs of laying hens. | Q44947701 | ||
| Increasing omega fatty acid content in cow's milk through diet manipulation: effect on milk flavor. | Q46078108 | ||
| Rate of acyl migration in lysophosphatidylcholine (LPC) is dependent upon the nature of the acyl group. Greater stability of sn-2 docosahexaenoyl LPC compared to the more saturated LPC species | Q46265694 | ||
| Roe-derived phospholipid administration enhances lymphatic docosahexaenoic acid-containing phospholipid absorption in unanesthetized rats | Q46339620 | ||
| Protective effect of docosahexaenoic acid against brain injury in ischemic rats | Q46355557 | ||
| Specific circulating phospholipids, acylcarnitines, amino acids and biogenic amines are aerobic exercise markers | Q46419983 | ||
| Endothelial lipase releases saturated and unsaturated fatty acids of high density lipoprotein phosphatidylcholine. | Q46440489 | ||
| Simultaneous quantification of cardiovascular disease related metabolic risk factors using liquid chromatography tandem mass spectrometry in human serum | Q46614634 | ||
| Identification of isobaric lyso-phosphatidylcholines in lipid extracts of gilthead sea bream (Sparus aurata) fillets by hydrophilic interaction liquid chromatography coupled to high-resolution Fourier-transform mass spectrometry. | Q46734512 | ||
| Relationship between the lipidome, inflammatory markers and insulin resistance | Q46908112 | ||
| Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer's disease | Q46939823 | ||
| Autotaxin expression is enhanced in frontal cortex of Alzheimer-type dementia patients | Q46985200 | ||
| Potential serum biomarkers and metabonomic profiling of serum in ischemic stroke patients using UPLC/Q-TOF MS/MS. | Q47150656 | ||
| Differential Pattern of Phospholipid Profile in the Temporal Cortex from E280A-Familiar and Sporadic Alzheimer's Disease Brains | Q47361754 | ||
| Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study. | Q47549112 | ||
| Fish intake, genetic predisposition to alzheimer's disease and decline in global cognition and memory in five cohorts of older persons. | Q47603750 | ||
| Fatty Acid-Binding Protein 5 at the Blood-Brain Barrier Regulates Endogenous Brain Docosahexaenoic Acid Levels and Cognitive Function. | Q47945490 | ||
| Mechanisms of lysophosphatidylcholine-induced demyelination: A primary lipid disrupting myelinopathy | Q48001723 | ||
| Mutations in ABCA7 in a Belgian cohort of Alzheimer's disease patients: a targeted resequencing study | Q48095601 | ||
| ABCA7 and Pathogenic Pathways of Alzheimer's Disease. | Q48104449 | ||
| Mixed brain pathologies account for most dementia cases in community-dwelling older persons | Q48136681 | ||
| Efficient Docosahexaenoic Acid Uptake by the Brain from a Structured Phospholipid. | Q48146086 | ||
| Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease | Q48159810 | ||
| Phospholipid class-specific brain enrichment in response to lysophosphatidylcholine docosahexaenoic acid infusion. | Q48172277 | ||
| Lysophosphatidylcholine export by human ABCA7. | Q48232397 | ||
| Preferential transfer of 2-docosahexaenoyl-1-lysophosphatidylcholine through an in vitro blood-brain barrier over unesterified docosahexaenoic acid. | Q48307793 | ||
| Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial | Q48400307 | ||
| Omega-3 polyunsaturated fatty acids ameliorate neuroinflammation and mitigate ischemic stroke damage through interactions with astrocytes and microglia | Q48425876 | ||
| Regional membrane phospholipid alterations in Alzheimer's disease | Q48524004 | ||
| Lysophosphatidylcholine from white muscle of bonito Euthynnus pelamis (Linnaeus): involvement of phospholipase A1 activity for its production. | Q48545969 | ||
| Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity | Q48546991 | ||
| Gene expression of fatty acid transport and binding proteins in the blood-brain barrier and the cerebral cortex of the rat: differences across development and with different DHA brain status | Q48604499 | ||
| Membrane fatty acid composition shows delta-6-desaturase abnormalities in Alzheimer's disease | Q48891132 | ||
| From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry | Q48930837 | ||
| Lipidome as a predictive tool in progression to type 2 diabetes in Finnish men. | Q49894555 | ||
| Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions. | Q50477361 | ||
| Identification of alpha-1 acid glycoprotein as a lysophospholipid binding protein: a complementary role to albumin in the scavenging of lysophosphatidylcholine. | Q50714412 | ||
| Dietary choline and phospholipid supplementation enhanced docosahexaenoic acid enrichment in egg yolk of laying hens fed a 2% Schizochytrium powder-added diet. | Q51041659 | ||
| Selective export of autotaxin from the endoplasmic reticulum. | Q51097936 | ||
| Lysophosphatidylcholine and amide as metabolites for detecting alzheimer disease using ultrahigh-performance liquid chromatography-quadrupole time-of-flight mass spectrometry-based metabonomics. | Q51793986 | ||
| Effect of type and level of fish oil supplementation on yolk fat composition and n-3 fatty acids retention efficiency in laying hens. | Q51945484 | ||
| Decreased phospholipase A2 activity in Alzheimer brains. | Q52019953 | ||
| Fatty Acid-Binding Protein 5 Facilitates the Blood-Brain Barrier Transport of Docosahexaenoic Acid. | Q52148129 | ||
| Maresins: Specialized Proresolving Lipid Mediators and Their Potential Role in Inflammatory-Related Diseases. | Q52576158 | ||
| Neural membrane phospholipids in Alzheimer disease. | Q53213229 | ||
| Reduced phosphoinositide concentrations in anterior temporal cortex of Alzheimer-diseased brains. | Q53303473 | ||
| Alzheimer's disease | Q55880664 | ||
| Untargeted metabolic profiling identifies altered serum metabolites of type 2 diabetes mellitus in a prospective, nested case control study | Q56969138 | ||
| Characterization of Positional Distribution of Fatty Acids and Triacylglycerol Molecular Compositions of Marine Fish Oils Rich in Omega-3 Polyunsaturated Fatty Acids | Q57176529 | ||
| Plasma Lipidomic Profiling and Risk of Type 2 Diabetes in the PREDIMED Trial | Q57456811 | ||
| The Impact of Docosahexaenoic Acid on Alzheimer's Disease: Is There a Role of the Blood-Brain Barrier? | Q38580477 | ||
| Lipidomics of human brain aging and Alzheimer's disease pathology. | Q38584554 | ||
| Metabolite patterns predicting sex and age in participants of the Karlsruhe Metabolomics and Nutrition (KarMeN) study | Q38622119 | ||
| The blood-brain barrier fatty acid transport protein 1 (FATP1/SLC27A1) supplies docosahexaenoic acid to the brain, and insulin facilitates transport | Q38723657 | ||
| Fatty Acid Binding Proteins Expressed at the Human Blood-Brain Barrier Bind Drugs in an Isoform-Specific Manner | Q38845819 | ||
| Cardiolipin and mitochondrial cristae organization | Q38881323 | ||
| Mitochondrial acyltransferases and glycerophospholipid metabolism | Q38885719 | ||
| Mechanisms of DHA transport to the brain and potential therapy to neurodegenerative diseases. | Q38920006 | ||
| Membrane raft domains and remodeling in aging brain | Q38946294 | ||
| Walking Pace and the Risk of Cognitive Decline and Dementia in Elderly Populations: A Meta-analysis of Prospective Cohort Studies. | Q39032234 | ||
| Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms | Q39591498 | ||
| Formation and transport of chylomicrons by enterocytes to the lymphatics | Q39735373 | ||
| Plasma metabolic profiling of Alzheimer's disease by liquid chromatography/mass spectrometry | Q39874746 | ||
| Plasma lipidomic profiles and cardiovascular events in a randomized intervention trial with the Mediterranean diet. | Q40081005 | ||
| Improvement of myocardial infarction risk prediction via inflammation-associated metabolite biomarkers | Q40310560 | ||
| Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease | Q41159549 | ||
| Dietary docosahexaenoic acid (DHA) as lysophosphatidylcholine, but not as free acid, enriches brain DHA and improves memory in adult mice. | Q41193473 | ||
| Plasma metabolic profiling of mild cognitive impairment and Alzheimer's disease using liquid chromatography/mass spectrometry | Q41681923 | ||
| Lipidomic profiling reveals distinct differences in plasma lipid composition in healthy, prediabetic, and type 2 diabetic individuals | Q41726561 | ||
| Plasma non-esterified docosahexaenoic acid is the major pool supplying the brain. | Q41817485 | ||
| A partially inactivating mutation in the sodium-dependent lysophosphatidylcholine transporter MFSD2A causes a non-lethal microcephaly syndrome | Q41928079 | ||
| Unsaturated fatty acids esterified in 2-acyl-l-lysophosphatidylcholine bound to albumin are more efficiently taken up by the young rat brain than the unesterified form | Q42089244 | ||
| The low density lipoprotein receptor is not necessary for maintaining mouse brain polyunsaturated fatty acid concentrations | Q42520124 | ||
| Analysis on the phenotype of E-FABP-gene knockout mice | Q42528637 | ||
| Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain | Q42557209 | ||
| Docosahexaenoic Acid | Q42740304 | ||
| Genetic ablation of CD36 does not alter mouse brain polyunsaturated fatty acid concentrations | Q43122479 | ||
| Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex | Q43181451 | ||
| The very low density lipoprotein receptor is not necessary for maintaining brain polyunsaturated fatty acid concentrations | Q43182650 | ||
| Brain membrane phospholipid alterations in Alzheimer's disease | Q43743686 | ||
| The effect of short-term overfeeding on serum lipids in healthy humans | Q43982876 | ||
| Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer's disease: potential role in disease pathogenesis | Q44163309 | ||
| Specific plasma lipid classes and phospholipid fatty acids indicative of dairy food consumption associate with insulin sensitivity. | Q44263608 | ||
| Decreased lysophosphatidylcholine/phosphatidylcholine ratio in cerebrospinal fluid in Alzheimer's disease | Q44536587 | ||
| P577 | publication date | 2020-03-19 | |
| P1433 | published in | Advances in Nutrition | Q20821073 |
| P1476 | title | Perspective: The Potential Role of Circulating Lysophosphatidylcholine in Neuroprotection against Alzheimer Disease |
| Q99731963 | Multi- and transgenerational effects following early-life exposure of zebrafish to permethrin and coumarin 47: Impact on growth, fertility, behavior and lipid metabolism | cites work | P2860 |
Search more.